Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The IL-7Rα pathway is quantitatively and functionally altered in CD8 T cells in multiple sclerosis.
Kreft KL, Verbraak E, Wierenga-Wolf AF, van Meurs M, Oostra BA, Laman JD, Hintzen RQ.
J Immunol. 2012 Feb 15;188(4):1874-83. Epub 2012 Jan 18.
Related citations
Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-γR2.
Conti L, De Palma R, Rolla S, Boselli D, Rodolico G, Kaur S, Silvennoinen O, Niccolai E, Amedei A, Ivaldi F, Clerico M, Contessa G, Uccelli A, Durelli L, Novelli F.
J Immunol. 2012 Feb 1;188(3):1011-8. Epub 2012 Jan 4.
Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy.
Smarr CB, Hsu CL, Byrne AJ, Miller SD, Bryce PJ.
J Immunol. 2011 Nov 15;187(10):5090-8. Epub 2011 Oct 5.
B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.
Schneider R, Mohebiany AN, Ifergan I, Beauseigle D, Duquette P, Prat A, Arbour N.
J Immunol. 2011 Oct 15;187(8):4119-28. Epub 2011 Sep 12.
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
Zhang X, Tao Y, Troiani L, Markovic-Plese S.
J Immunol. 2011 Sep 15;187(6):3431-7. Epub 2011 Aug 19.
The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation.
Kofler DM, Severson CA, Mousissian N, De Jager PL, Hafler DA.
J Immunol. 2011 Sep 15;187(6):3286-91. Epub 2011 Aug 17.
Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11.
Zhang J, Zhang Y, Dutta DJ, Argaw AT, Bonnamain V, Seto J, Braun DA, Zameer A, Hayot F, Lòpez CB, Raine CS, John GR.
J Immunol. 2011 Aug 1;187(3):1129-41. Epub 2011 Jun 27.
Notch signaling regulates mouse and human Th17 differentiation.
Keerthivasan S, Suleiman R, Lawlor R, Roderick J, Bates T, Minter L, Anguita J, Juncadella I, Nickoloff BJ, Le Poole IC, Miele L, Osborne BA.
J Immunol. 2011 Jul 15;187(2):692-701. Epub 2011 Jun 17.
Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
Thakker P, Marusic S, Stedman NL, Lee KL, McKew JC, Wood A, Goldman SJ, Leach MW, Collins M, Kuchroo VK, Wolf SF, Clark JD, Hassan-Zahraee M.
J Immunol. 2011 Aug 15;187(4):1986-97. Epub 2011 Jul 11.
Comment on "Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis".
van Noort JM, Amor S, Bajramovic JJ.
J Immunol. 2011 Jul 1;187(1):3; author reply 3-4. No abstract available.
Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis.
Jiang W, Chai NR, Maric D, Bielekova B.
J Immunol. 2011 Jul 15;187(2):781-90. Epub 2011 Jun 10.
Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.
Raddassi K, Kent SC, Yang J, Bourcier K, Bradshaw EM, Seyfert-Margolis V, Nepom GT, Kwok WW, Hafler DA.
J Immunol. 2011 Jul 15;187(2):1039-46. Epub 2011 Jun 8.
Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients.
Johnson TA, Evans BL, Durafourt BA, Blain M, Lapierre Y, Bar-Or A, Antel JP.
J Immunol. 2011 Jul 1;187(1):570-9. Epub 2011 May 27.
Comment on "Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice".
Disanto G, Handel AE, Morahan JM, Ramagopalan SV.
J Immunol. 2011 Apr 1;186(7):3803-4. No abstract available.
B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis.
Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S.
J Immunol. 2011 Apr 1;186(7):4518-26. Epub 2011 Mar 2.
Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.
Rothbard JB, Zhao X, Sharpe O, Strohman MJ, Kurnellas M, Mellins ED, Robinson WH, Steinman L.
J Immunol. 2011 Apr 1;186(7):4263-8. Epub 2011 Feb 25.
Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis.
Sayed BA, Walker ME, Brown MA.
J Immunol. 2011 Mar 15;186(6):3294-8. Epub 2011 Feb 16.
Glatiramer acetate treatment of multiple sclerosis: an immunological perspective.
Racke MK, Lovett-Racke AE.
J Immunol. 2011 Feb 15;186(4):1887-90. Review.
CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis.
Baecher-Allan CM, Costantino CM, Cvetanovich GL, Ashley CW, Beriou G, Dominguez-Villar M, Hafler DA.
J Immunol. 2011 Mar 15;186(6):3317-26. Epub 2011 Feb 7.
Comment on "Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects".
Handel AE, De Luca GC, Ramagopalan SV.
J Immunol. 2011 Jan 15;186(2):647; author reply 648. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on